Silicon Laboratories stock triggered by valuation reset

Silicon Laboratories (SLAB) is back in focus after recent trading left the stock near its implied fair value, with the latest close at US$218.42 and a modest 2.0% gap to consensus value estimates.

Over the past year, Silicon Laboratories has paired a strong year to date share price return of 65.56% with a 1 year total shareholder return of 48.22%. This suggests momentum has been building even as recent weekly moves have been more muted.

If you are looking for more ideas in related areas, this could be a good moment to broaden your watchlist with 51 AI infrastructure stocks

With Silicon Laboratories trading close to analyst price targets and recent gains already strong, the key question is whether today’s valuation still leaves upside or if the market is already pricing in future growth.

Most Popular Narrative: 2% Undervalued

Silicon Laboratories is trading at $218.42 compared with a widely followed fair value estimate of about $222.86, so the narrative has only a small implied upside built in while still assuming meaningful progress on growth and margins.

Ongoing rollout of new, highly integrated, energy-efficient wireless platforms (Series 2 and Series 3) positions Silicon Labs to capture increased market share and supports higher ASPs, which is likely to drive top-line growth and gross margin improvement.

Want to understand why an unprofitable Silicon Laboratories still earns a premium tag in this narrative? Revenue compounding, margin rebuild, and a rich earnings multiple all sit at the core of the fair value story, and the full narrative joins those moving parts into a single valuation path.

Result: Fair Value of $222.86 (UNDERVALUED)

However, Silicon Laboratories still faces two key swing factors: tougher wireless IoT competition that could pressure pricing and margins, and chip commoditization that may weaken its premium positioning.

Another View on Silicon Laboratories Valuation

While the prevailing Silicon Laboratories narrative points to around 2% upside to a fair value of $222.86, our DCF model paints a very different picture, with a future cash flow value of $58.59 per share, which would frame the stock as materially overvalued. Which valuation anchor do you trust more: a cash flow based model or earnings style assumptions baked into analyst targets?

Next Steps

If this balanced mix of optimism and concern around Silicon Laboratories leaves you undecided, take a closer look at the underlying data and form your own stance with 1 key reward and 2 important warning signs

Looking for more investment ideas beyond Silicon Laboratories?

Do not stop with Silicon Laboratories. Broaden your opportunity set and keep your portfolio ideas fresh by scanning other stocks that meet clear, data backed criteria.

• Spot potential upside early by tracking companies that look mispriced against fundamentals with the help of 44 high quality undervalued stocks
• Strengthen your core holdings by reviewing companies screened for sturdy finances and sensible metrics through the solid balance sheet and fundamentals stocks screener (48 results)
• Get ahead of the crowd by searching a focused list of lesser known prospects using the screener containing 19 high quality undiscovered gems

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.